FDA
-
-
-
-
-
-
-
Royalty Pharma reports $4.7 billion in transactions for 2025
-
-
-
-
-
-
-
Royalty Pharma Acquires Remaining Royalty Interest in Roche’s Evrysdi for $240 Million and Potential Milestones
-
-
-
-
-
-
-
Royalty Pharma Reports Third Quarter 2025 Results
-
-
-
-
-
-
-
Royalty Pharma to acquire Imdelltra royalty interest for up to $950 million
-
-
-
-
-
-
-
Royalty Pharma (RPRX) appoints Vlad Coric to Board
-
-
-
-
-
-
-
Royalty Pharma Reports Third Quarter 2024 Results
-
-
-
-
-
-
-
Royalty Pharma Reports Second Quarter 2024 Results
-
327,748 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

